etomoxir has been researched along with ryanodine in 1 studies
Studies (etomoxir) | Trials (etomoxir) | Recent Studies (post-2010) (etomoxir) | Studies (ryanodine) | Trials (ryanodine) | Recent Studies (post-2010) (ryanodine) |
---|---|---|---|---|---|
260 | 8 | 93 | 2,894 | 3 | 237 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Rupp, H; Vetter, R | 1 |
1 other study(ies) available for etomoxir and ryanodine
Article | Year |
---|---|
CPT-1 inhibition by etomoxir has a chamber-related action on cardiac sarcoplasmic reticulum and isomyosins.
Topics: Animals; Calcium; Calcium-Binding Proteins; Calcium-Transporting ATPases; Carnitine O-Palmitoyltransferase; Cyclic AMP-Dependent Protein Kinases; Epoxy Compounds; Heart; Heart Ventricles; Ion Transport; Lipids; Male; Myosins; Phosphorylation; Rats; Rats, Wistar; Ryanodine; Sarcoplasmic Reticulum; Stereoisomerism; Troponin; Troponin I | 1994 |